Cargando…

Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies

Currently, the assessment of the neurobehavioral consequences of repeated cannabis use is restricted to studies in which brain function of chronic cannabis users is compared to that of non-cannabis using controls. The assumption of such studies is that changes in brain function of chronic users are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramaekers, Johannes G., Theunissen, Eef L., van Ruitenbeek, Peter, Mason, Natasha L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046729/ https://www.ncbi.nlm.nih.gov/pubmed/35492732 http://dx.doi.org/10.3389/fpsyt.2022.870750

Ejemplares similares

A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022)

Methylphenidate as a treatment option for substance use disorder: a transdiagnostic perspective
por: van Ruitenbeek, Peter, et al.
Publicado: (2023)

Cannabis sativa (Hemp) Seeds, Δ(9)-Tetrahydrocannabinol, and Potential Overdose
por: Yang, Yi, et al.
Publicado: (2017)

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
por: Reckweg, Johannes T., et al.
Publicado: (2023)

Identification of candidate genes affecting Δ(9)-tetrahydrocannabinol biosynthesis in Cannabis sativa
por: Marks, M. David, et al.
Publicado: (2009)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Adolescent Δ(9)-Tetrahydrocannabinol Exposure Selectively Impairs Working Memory but Not Several Other mPFC-Mediated Behaviors
por: Chen, Han-Ting, et al.
Publicado: (2020)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2020)

Continuous-Flow Synthesis of Δ(9)-Tetrahydrocannabinol and Δ(8)-Tetrahydrocannabinol from Cannabidiol
por: Bassetti, Benedetta, et al.
Publicado: (2023)

Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model
por: Casey, Sherelle L., et al.
Publicado: (2022)

Behavioral Neuroadaptation to Alcohol: From Glucocorticoids to Histone Acetylation
por: Mons, Nicole, et al.
Publicado: (2016)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
por: Chetia, Swapnali, et al.
Publicado: (2020)

Enkephalin as a Pivotal Player in Neuroadaptations Related to Psychostimulant Addiction
por: Mongi-Bragato, Bethania, et al.
Publicado: (2018)

Toxicological Properties of Δ(9)-tetrahydrocannabinol and Cannabidiol
por: Černe, Katarina
Publicado: (2020)

Beyond Δ9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis
por: Monti, Manuela Carla, et al.
Publicado: (2022)

Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users
por: Mason, Natasha L., et al.
Publicado: (2019)

A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ(9)-tetrahydrocannabinol: Δ(9)-Tetrahydrocannabiphorol
por: Citti, Cinzia, et al.
Publicado: (2019)

Identification of Terpenoid Chemotypes Among High (−)-trans-Δ(9)- Tetrahydrocannabinol-Producing Cannabis sativa L. Cultivars
por: Fischedick, Justin T.
Publicado: (2017)

Δ(9)-tetrahydrocannabinol discrimination: Effects of route of administration in mice
por: Marusich, Julie A., et al.
Publicado: (2023)

Δ9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity
por: Castelli, M. Paola, et al.
Publicado: (2014)

Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users
por: Ramaekers, Johannes G., et al.
Publicado: (2010)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
por: Bartoli, Francesco, et al.
Publicado: (2021)

Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ(9)-tetrahydrocannabinol: a pilot study
por: Peters, Erica N., et al.
Publicado: (2021)

Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide
por: Hassenberg, Christoph, et al.
Publicado: (2020)

Tolerance and dependence to Δ(9)-tetrahydrocannabinol in rhesus monkeys: Activity assessments
por: Wilkerson, Jenny L., et al.
Publicado: (2019)

Δ(9)-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2018)

The dimerization of Δ(9)-tetrahydrocannabinolic acid A (THCA-A)
por: Cuadari, Arben, et al.
Publicado: (2019)

Acute human exposure assessment to tetrahydrocannabinol (Δ(9)‐THC)
por: Arcella, Davide, et al.
Publicado: (2020)

Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial
por: Zamarripa, C. Austin, et al.
Publicado: (2023)

Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication
por: Theunissen, Eef L., et al.
Publicado: (2011)

Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts
por: Nallathambi, Rameshprabu, et al.
Publicado: (2017)

Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath
por: Wurz, Gregory T., et al.
Publicado: (2022)

Adverse effects of Δ(9)-tetrahydrocannabinol on neuronal bioenergetics during postnatal development
por: Beiersdorf, Johannes, et al.
Publicado: (2020)

Genetic Dissection of Behavioural and Autonomic Effects of Δ(9)-Tetrahydrocannabinol in Mice
por: Monory, Krisztina, et al.
Publicado: (2007)

Selective effects of Δ(9)-tetrahydrocannabinol on medium spiny neurons in the striatum
por: Fernández-Cabrera, Mónica R., et al.
Publicado: (2018)

Cannabidiol Does Not Convert to Δ(9)-Tetrahydrocannabinol in an In Vivo Animal Model
por: Wray, Louise, et al.
Publicado: (2017)

Δ(9)‐Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo
por: Huerga‐Gómez, Alba, et al.
Publicado: (2020)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
por: Rao, Qianru, et al.
Publicado: (2022)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
por: Arkell, Thomas R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cgbig2u4n4mboajecdptnr45qj